GFR trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes GFR achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 30, 2026, Greenfire Resources Ltd. (GFR) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $416M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, GFR trades at a trailing P/E of 12.7x. Analysts expect EPS to grow +67.6% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MEGMontrose Environmental Group, Inc. | $566M | $15.64 | $49.33 | +215.4% | Buy | 122.1x | 12 |
CVECenovus Energy Inc. | $47.1B | $24.99 | $29.00 | +16.0% | Hold | 5.6x | 27 |
SUSuncor Energy Inc. | $63.9B | $53.81 | $71.00 | +31.9% | Buy | 5.9x | 31 |
IMOImperial Oil Limited | $56.3B | $113.25 | $44.99 | -60.3% | Hold | 8.9x | 22 |
CNQCanadian Natural Resources Limited | $82.0B | $39.31 | $35.00 | -11.0% | Buy | 9.2x | 37 |
OVVOvintiv Inc. | $15.0B | $53.20 | $69.25 | +30.2% | Buy | 6.7x | 26 |
BTEBaytex Energy Corp. | $3.0B | $4.01 | — | — | Buy | 9.2x | 16 |
PBAPembina Pipeline Corporation | $27.1B | $46.70 | $38.76 | -17.0% | Buy | 15.3x | 16 |
HALHalliburton Company | $28.5B | $34.09 | $39.64 | +16.3% | Buy | 14.5x | 64 |
SLBSLB N.V. | $69.3B | $46.38 | $60.46 | +30.4% | Buy | 17.9x | 66 |
Quick answers to the most common questions about buying GFR stock.
The consensus price target for GFR is $N/A, close to the current price of $5.74 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
GFR has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
GFR's current price is $5.74 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for GFR, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
GFR is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month GFR stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
GFR appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
GFR analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.